Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 240-815-0 | CAS number: 16752-77-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 991
- Report date:
- 1991
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 403 (Acute Inhalation Toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPP 81-3 (Acute inhalation toxicity)
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- other: MAFF Testing Guideline for Acute Inhalation Toxicity Study (59 NohSan No. 4200)
- Deviations:
- no
- GLP compliance:
- yes
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- Methomyl
- EC Number:
- 240-815-0
- EC Name:
- Methomyl
- Cas Number:
- 16752-77-5
- Molecular formula:
- C5H10N2O2S
- IUPAC Name:
- (E)-[1-(methylsulfanyl)ethylidene]amino N-methylcarbamate
- Test material form:
- solid: crystalline
Constituent 1
- Specific details on test material used for the study:
- - Substance name: Ethanimidothioic acid,N-[[(methylamino)carbonyl]oxy]-, methyl ester
- Substance ID: DPX-X1179
- Lot#: X1179-427
- Purity: 97.7%
Test animals
- Species:
- rat
- Strain:
- other: Crl:CD BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Laboratories, Kingston, New York
- Age at study initiation: Approximately 8 weeks
- Weight at study initiation: Males: 223 to 272 grams; Females: 183 to 219 grams
- Fasting period before study: Not specified
- Housing: Rats were housed either singly or in pairs (sexes separate) in 8" x 14" x 8" suspended, stainless steel, wire-mesh cages.
- Diet: Purina Certified Rodent Chow # 5002 ad libitum
- Water: Tap water ad libitum
- Acclimation period: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature: 23 ± 2°C
- Humidity: 50 ± 10%
- Photoperiod: 12 hrs dark / hrs light
Administration / exposure
- Route of administration:
- inhalation: aerosol
- Type of inhalation exposure:
- nose only
- Vehicle:
- other: Distilled water
- Mass median aerodynamic diameter (MMAD):
- >= 1.3 - <= 3.8 µm
- Geometric standard deviation (GSD):
- >= 2.3 - <= 2.9
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus: An atmosphere of test substance was generated by suspending the solid in distilled water at a concentration of 3% and generating an aerosol using an Airlife Solo-Sphere nebulizer.
- Exposure chamber volume: 29-L
- Method of holding animals in test chamber: During exposure, rats were restrained in perforated, polycarbonate cylinders with conical nose pieces. The restrainers were inserted into the face plate of a 29-L, cylindrical, glass exposure chamber so that only the nose of each rat protruded into the chamber.
- Source and rate of air: Pressurized air introduced at the Solo-Sphere (7.8-12 L/min) atomized the test material and swept the resulting aerosol into the 29-L, cylindrical, glass exposure chamber. Filtered dilution air was introduced into the chamber at rates of 4.5-13 L/min.
- System of generating aerosols: Using Airlife Solo-sphere nebulizer
- Method of particle size determination: Gravimetric analysis
- Treatment of exhaust air: The chamber atmosphere was exhausted through a glass bubbler filled with water and an MSA particulate filter prior to being discharged in to the fume hood.
- Temperature, humidity, pressure in air chamber: Airflow during the exposures ranged from 14.4-22.4 L/min. Chamber temperatures ranged from 21 to 25°C, relative humidity ranged from 70% to 100%, and the oxygen concentration was 21%.
TEST ATMOSPHERE
- Brief description of analytical method used: Chromatographic analyses of the gravimetric filters from exposures are used for measuring mean total analyrtical concentration.
- Samples taken from breathing zone: yes. The atmospheric concentration of test substance was determined at approximately 30-minute intervals during each exposure using gravimetric
analysis. Four to 10 litre samples of chamber atmosperes were drawn from breathing zone of the rats through a 25 mm filter cassette that contained a preweighed Gelman glass fiber (Type A/E) filter. Cahn Model C-31 Microbalance and then placed in a dessicator. Concentration of test subatnce was calculated from the difference in the preand post-sampling dry filter weights.
TEST ATMOSPHERE
- Particle size distribution: Chamber test atmospheres consisted of 6.2 to 40% of the particles less than 1 µm, 38 to 84% less than 3 µm, and 85 to 99% less than 10 µm.
- MMAD (Mass median aerodynamic diameter) and Geometric standard deviation: 1.3 to 3.8µm and GSD ranged from 2.3 to 2.9 - Analytical verification of test atmosphere concentrations:
- yes
- Remarks:
- The mean analytical concentrations of test substance were 0.126, 0.160, 0.179, 0.215, and 0.304 mg/L for 0.137, 0,181, 0.182, 0.232, and 0.326, respectively.
- Duration of exposure:
- 4 h
- Concentrations:
- 0.137, 0.181, 0.182, 0.232, and 0.326 mg/L
- No. of animals per sex per dose:
- 5
- Control animals:
- yes
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Rats were weighed and observed for clinical signs of toxicity daily, excluding test Days 5, 11, and 12 for the 0.137 mg/L group, test Days 4, 10, and 11 for the 0.181 mg/L group, test Days 6, 7, 13, and 14 for the 0.182 mg/L group, test Days 4 , 5, 11, and 12 for the 0.232 group, and test Days 6, 7, 13, and 14 for the 0.326 mg/L group.
- Necropsy of survivors performed: yes
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- 0.258 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- No rats died that were exposed to concentrations of 0.137 or 0.181 mg/L. In other exposures, 1 of 10 rats died at 0.182 mg/L, 6 of 10 rats died at 0.232 mg/L, and 7 of 10 rats died at 0.326 mg/L. All rats that died did so during the exposures. There was no difference between the response of the male and female rats based on mortality.
- Clinical signs:
- other: Clinical signs of toxicity assessed during the exposure included nasal discharge and salivation. Nasal movement was assessed to determine mortality of the rats. Upon removal of the rats from the restrainers immediately following exposure, the clinical sig
- Body weight:
- By the first day post exposure, most of the rats exhibited weight loss. Rats began gaining weight by the second day of recovery and despite some transient weight losses experienced an overall gain by the end of recovery.
- Gross pathology:
- All exposed rats were sacrificed and subjected to a gross pathological examination 14 days after exposure. Gross abnormalities found in rats which were found dead included expanded lungs and edema of the pleural cavity. These abnormalities are considered to be associated with stress resulting from systemic toxicity. Gross observations included small bilateral testes and seminal vesicles in 1 male rat and a unilateral dilatation of the renal pelvis in another male rat. These findings were considered to be incidental. No target organ was identified in these rats.
Applicant's summary and conclusion
- Interpretation of results:
- Category 2 based on GHS criteria
- Conclusions:
- LC50 Rat (Male/Female): 0.258 mg/L
- Executive summary:
The study was conducted according to test guideline OECD 403 and US EPA 81-3 to determine the acute inhalation toxicity of test substance in rats. Five groups of 5 male and 5 female CRL:CD BR rats each were exposed to an atmosphere of test substance for a single, 4-hour exposure period. The test atmosphere was generated by suspending the test material in distilled water and aerosolizing the mixture. During the exposure, the concentration of the test aerosol was determined by gravimetric analysis A subsequent liquid chromatographic analysis of the eluent from the desorption of select gravimetric filters was carried out to determine the amount of test substance collected. In the pursuant 14-day recovery period, rats were weighed and observed for clinical signs of toxicity. All rats underwent gross pathological examination at the end of the recovery period.
Rats were exposed to dry weight concentrations of 0.137, 0.181, 0.182, 0.232, and 0.326 mg/L of test substance. Total particulate was determined to be homogeneously distributed in the exposure chamber. The test aerosol during the exposure was characterized by measurement of a mass median aerodynamic diameter (MMAD). The MMAD of the aerosols generated ranged from 1.3 to 3.8 µm with 6.2 to 40% of the particles being less than 1 µm and 38 to 84% of the particles being less than 3 µm.
1 of 10 rats exposed to test substance died following exposure at 0.182 mg/L. 6 of 10 rats exposed at 0.232 mg/L died and 7 of 10 rats died following exposure at 0.326 mg/L. All rats exposed to test substance at 0.137 or 0.181 mg/L survived exposure and pursuant recovery period.
Clinical signs of toxicity observed immediately following exposures included diarrhea, lethargy, and ocular or nasal discharge. Rats surviving exposures at levels which produced mortality also showed signs of abnormal gait or mobility, low posture, tremors, hyperactivity, hyperreactivity, and muscle fasciculations. These clinical signs were transient and were absent on the day following their initial observation. These clinical signs are consistent clinical signs commonly observed in materials from the family of methyl carbamate insecticides. Wet fur, a common sign associated with the restrainers used for nose-only exposure, was noted in most of the rats immediately following the exposure. Other clinical signs observed during the recovery period included stained and/or ruffled fur, diarrhea, hunched posture, ocular and/or nasal discharge, irregular respiration, and lethargy. Corneal opacity was noted in one animal exposed to 0.232 mg/L of test substance. Rats that survived exposures experienced some weight loss immediately following exposure and some transient weight loss later in the recovery, but all rats showed an overall weight gain by the end of the 14-day recovery period. Gross pathological examination revealed no evidence of organ-specific toxicity in any rats.
Under the conditions of this test, the LC50, for test substance was 0.258 mg/L. On an acute inhalation basis, test substance was considered to have moderate toxicity (LC50, between 0.2 mg/L and 0.8 mg/L).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.

EU Privacy Disclaimer
This website uses cookies to ensure you get the best experience on our websites.